Us2.ai secures US$15 mil Series A to improve detection of cardiovascular disease
Us2.ai announced that it has raised US$15 million in a Series A round led by IHH Healthcare and Heal Partners, with participation from Pappas Capital.
eko.ai raises US$4mil in funding to automate the fight against heart disease
Round co-led by Sequoia India and Singapore government-linked strategic investor EDBI.
Singapore approves medical AI software for automated analysis of vascular ultrasound
See-Mode’s first product, Augmented Vascular Analysis, has been approved as a Class B medical device.
Ark launches with US$40mil Series A investment
Medtech company established via a merger between A*STAR MedTech spin-off MiRXES and venture capital firm Venturecraft.
SGInnovate completes investment in deep tech startup NDR Medical Technology
Investment marks an important milestone for Singapore’s medtech startup scene.
Saving lives with the early detection of cancer
Early cancer detection saves lives and one Malaysian company – Mobecomm Technologies – is providing the technology to do just that.
What’s Next 2016: CEO of Khazanah-owned VC firm Xeraya joins line-up
Fares Zahir, the CEO of Xeraya Capital, a Khazanah-owned VC firm, joins the What’s Next conference as a panellist, and here shares what the low-key fund does and how some of its investments have fared.
SEA startups: France wants you!
The French government wants South-East Asian startups, including those based in Singapore, to become of its ecosystem via the French Tech Ticket competition.
SJMC harnesses Varian radiotherapy tech for cancer treatment
SUBANG Jaya Medical Centre (SJMC) said it will be using the Varian TrueBeam Radiotherapy System, which it described as a breakthrough technology in the fight against cancer.